These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38866971)

  • 1. AI for the prediction of early stages of Alzheimer's disease from neuroimaging biomarkers - A narrative review of a growing field.
    Rudroff T; Rainio O; Klén R
    Neurol Sci; 2024 Nov; 45(11):5117-5127. PubMed ID: 38866971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latent diffusion model-based MRI superresolution enhances mild cognitive impairment prognostication and Alzheimer's disease classification.
    Yoon D; Myong Y; Kim YG; Sim Y; Cho M; Oh BM; Kim S
    Neuroimage; 2024 Aug; 296():120663. PubMed ID: 38843963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting changes in brain metabolism and progression from mild cognitive impairment to dementia using multitask Deep Learning models and explainable AI.
    García-Gutiérrez F; Hernández-Lorenzo L; Cabrera-Martín MN; Matias-Guiu JA; Ayala JL;
    Neuroimage; 2024 Aug; 297():120695. PubMed ID: 38942101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer's disease.
    Wang X; Huang W; Su L; Xing Y; Jessen F; Sun Y; Shu N; Han Y
    Mol Neurodegener; 2020 Sep; 15(1):55. PubMed ID: 32962744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AI-driven innovations in Alzheimer's disease: Integrating early diagnosis, personalized treatment, and prognostic modelling.
    Kale M; Wankhede N; Pawar R; Ballal S; Kumawat R; Goswami M; Khalid M; Taksande B; Upaganlawar A; Umekar M; Kopalli SR; Koppula S
    Ageing Res Rev; 2024 Nov; 101():102497. PubMed ID: 39293530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
    Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
    J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging and analytical methods for studying the pathways from mild cognitive impairment to Alzheimer's disease: protocol for a rapid systematic review.
    Ahmadzadeh M; Christie GJ; Cosco TD; Moreno S
    Syst Rev; 2020 Apr; 9(1):71. PubMed ID: 32241302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Explainable AI-based Deep-SHAP for mapping the multivariate relationships between regional neuroimaging biomarkers and cognition.
    Bhattarai P; Thakuri DS; Nie Y; Chand GB
    Eur J Radiol; 2024 May; 174():111403. PubMed ID: 38452732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
    Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
    BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2012 Feb; 8(1 Suppl):S1-68. PubMed ID: 22047634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of clinical and biomarker conformed Alzheimer's disease and mild cognitive impairment from multi-feature brain structural MRI using age-correction from a large independent lifespan sample.
    Li B; Zhang M; Riphagen J; Morrison Yochim K; Li B; Liu J; Salat DH;
    Neuroimage Clin; 2020; 28():102387. PubMed ID: 32871388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and prognosis of Alzheimer's disease using brain morphometry and white matter connectomes.
    Wang Y; Xu C; Park JH; Lee S; Stern Y; Yoo S; Kim JH; Kim HS; Cha J;
    Neuroimage Clin; 2019; 23():101859. PubMed ID: 31150957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating AI in fighting advancing Alzheimer: diagnosis, prevention, treatment, monitoring, mechanisms, and clinical trials.
    Angelucci F; Ai AR; Piendel L; Cerman J; Hort J
    Curr Opin Struct Biol; 2024 Aug; 87():102857. PubMed ID: 38838385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease.
    Giorgio J; Landau SM; Jagust WJ; Tino P; Kourtzi Z;
    Neuroimage Clin; 2020; 26():102199. PubMed ID: 32106025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Shen L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2013 Sep; 9(5):e111-94. PubMed ID: 23932184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment.
    Xu L; Wu X; Chen K; Yao L
    Comput Methods Programs Biomed; 2015 Nov; 122(2):182-90. PubMed ID: 26298855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review.
    Borchert RJ; Azevedo T; Badhwar A; Bernal J; Betts M; Bruffaerts R; Burkhart MC; Dewachter I; Gellersen HM; Low A; Lourida I; Machado L; Madan CR; Malpetti M; Mejia J; Michopoulou S; Muñoz-Neira C; Pepys J; Peres M; Phillips V; Ramanan S; Tamburin S; Tantiangco HM; Thakur L; Tomassini A; Vipin A; Tang E; Newby D; ; Ranson JM; Llewellyn DJ; Veldsman M; Rittman T
    Alzheimers Dement; 2023 Dec; 19(12):5885-5904. PubMed ID: 37563912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Random forest feature selection, fusion and ensemble strategy: Combining multiple morphological MRI measures to discriminate among healhy elderly, MCI, cMCI and alzheimer's disease patients: From the alzheimer's disease neuroimaging initiative (ADNI) database.
    Dimitriadis SI; Liparas D; Tsolaki MN;
    J Neurosci Methods; 2018 May; 302():14-23. PubMed ID: 29269320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.